€100m for R&D centre at Warsaw Medical Academy
The Cabinet has earmarked €100m for the construction of a Pre-Clinical Research and Technology Centre (CEPT), coordinated by the Medical Academy (AM) in Warsaw. This issue, as well as other projects financed from EU funds as part of the Innovative Economy Programme, was covered in the previous issue of Pharma Poland News (“Grants for research projects in medicine and pharmacology”). The Centre is to be completed in six years’ time.
The construction will cost PLN 180m (€47m) and equipment of the laboratories a further PLN 680m (€178m), so in order to finance the total amount, the AM will also seek institutional and commercial partners interested in investing in the Centre to conduct their own research there later. The aim is to create one of the most technologically advanced research centres in Europe.
The Centre is to comprise 10 state-of-the-art laboratories, where research will be conducted on the structure and functioning of proteins in the human body, biotechnology, nanotechnology, and new medicines. Scientists will work there on new technologies to combat lifestyle and age-related diseases, e.g. Parkinson’s and Alzheimer’s. Four labs will be created on the AM campus, and the other six on sites belonging to the Polish Academy of Science and Warsaw University, which, with the Warsaw University of Technology, are partners in the project.
In addition to the labs, the Centre will also have a high-powered computing unit and accommodation for firms engaged in implementing the results of research.